Centessa Pharmaceuticals (CNTA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Centessa Pharmaceuticals

    NASDAQ: CNTA · Real-Time Price · USD
    23.26
    0.25 (1.09%)
    At close: Sep 26, 2025, 3:59 PM
    23.72
    1.98%
    After-hours: Sep 26, 2025, 06:38 PM EDT

    Centessa Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 383.22M 128.03M 393.64M 595.08M
    Short-Term Investments
    		 98.96M 128.52M n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 2.05M 2.55M 45.98M 34.39M
    Receivables
    		 45.3M 39.15M 26.72M 16.81M
    Inventory
    		 n/a n/a -29.99M -17.81M
    Other Current Assets
    		 1.78M 1.62M 3.27M 993K
    Total Current Assets
    		 536.41M 315.09M 393.64M 595.08M
    Property-Plant & Equipment
    		 11.76M 12.95M 1.17M 162K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 40.39M 45.15M 50.66M 34.55M
    Total Assets
    		 576.8M 360.25M 444.31M 629.63M
    Account Payables
    		 7.14M 11.81M 13.84M 7.3M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 10.18M 839K 2.27M 871K
    Total Current Liabilities
    		 58M 39.38M 38.34M 24.64M
    Long-Term Debt
    		 108.94M 75.7M 69.8M 75.7M
    Other Long-Term Liabilities
    		 29K 29K n/a 37.74M
    Total Long-Term Liabilities
    		 117.25M 84.62M 108.14M 138.08M
    Total Liabilities
    		 175.25M 124M 108.14M 138.08M
    Total Debt
    		 117.23M 84.59M 69.8M 75.7M
    Book Value
    		 401.55M 236.24M 336.17M 491.55M
    Book Value Per Share
    		 3.51 2.46 3.60 5.46
    Common Stock
    		 359K 273K 265K 252K
    Retained Earnings
    		 -988.7M -752.95M -601.86M -385.65M
    Comprehensive Income
    		 4.21M 1.49M -1.5M 688K
    Shareholders Equity
    		 401.55M 236.24M 336.17M 491.55M
    Total Investments
    		 98.96M 128.52M n/a n/a

    Add to Watchlist